Skip to main content

EDGEWELL PERSONAL CARE Co

For the period ended Dec 31, 2023. Filed Feb 7, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2023 · Filed Feb 7, 2024

EPC$27.99-2.0%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Item 1. Financial Statements

Condensed Consolidated Statements of Earnings and Comprehensive Income for the three months ended December 31, 2023 and 20223
Condensed Consolidated Balance Sheets as of December 31, 2023 and September 30, 20234
Condensed Consolidated Statements of Cash Flows for the three months ended December 31, 2023 and 20225
Condensed Consolidated Statements of Changes in Shareholders’ Equity for the three months ended December 31, 2023 and 20226
Notes to Condensed Consolidated Financial Statements7
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations20
Item 3.Quantitative and Qualitative Disclosures About Market Risk30
Item 4.Controls and Procedures31
PART II.OTHER INFORMATION
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds32
Item 5.Other Information32
Item 6.Exhibits33
SIGNATURE34

PART I - FINANCIAL INFORMATION

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME

(unaudited, in millions, except per share data)

Three Months EndedDecember 31,
20232022
Net sales$488.9$469.1
Cost of products sold291.2279.5
Gross profit197.7189.6
Selling, general and administrative expense103.395.7
Advertising and sales promotion expense48.245.9
Research and development expense13.313.4
Restructuring charges6.82.7
Operating income26.131.9
Interest expense associated with debt19.819.9
Other expense (income), net0.3(5.0)
Earnings before income taxes6.017.0
Income tax provision1.24.6
Net earnings$4.8$12.4
Earnings per share:
Basic net earnings per share$0.10$0.24
Diluted net earnings per share$0.09$0.24
Statements of Comprehensive Income:
Net earnings$4.8$12.4
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments27.048.0
Pension and postretirement activity, net of tax (benefit) of $(0.6) and $(0.1)(0.1)(0.2)
Deferred loss on hedging activity, net of tax (benefit) of $(1.6) and $(3.8)(3.4)(8.2)
Total other comprehensive income, net of tax23.539.6
Total comprehensive income$28.3$52.0

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited, in millions, except share data)

December 31,2023September 30,2023
Assets
Current assets
Cash and cash equivalents$214.2$216.4
Trade receivables, less allowance for doubtful accounts of $6.1 and $5.6112.5106.2
Inventories521.9492.4
Other current assets156.9147.4
Total current assets1,005.5962.4
Property, plant and equipment, net333.5337.9
Goodwill1,337.11,331.4
Other intangible assets, net970.1973.8
Other assets141.0135.2
Total assets$3,787.2$3,740.7
Liabilities and Shareholders’ Equity
Current liabilities
Notes payable$24.2$19.5
Accounts payable197.5194.4
Other current liabilities246.0309.5
Total current liabilities467.7523.4
Long-term debt1,452.31,360.7
Deferred income tax liabilities136.9136.4
Other liabilities184.5179.7
Total liabilities2,241.42,200.2
Shareholders’ equity
Preferred shares, $0.01 par value, 10,000,000 authorized; none issued or outstanding——
Common shares, $0.01 par value, 300,000,000 authorized; 65,251,989 issued; 50,030,286 and 50,118,789 outstanding0.70.7
Additional paid-in capital1,568.91,593.8
Retained earnings1,019.31,022.1
Common shares in treasury at cost, 15,221,703 and 15,133,200(896.6)(906.1)
Accumulated other comprehensive loss(146.5)(170.0)
Total shareholders’ equity1,545.81,540.5
Total liabilities and shareholders’ equity$3,787.2$3,740.7

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited, in millions)

Three Months EndedDecember 31,
20232022
Cash Flow from Operating Activities
Net earnings$4.8$12.4
Depreciation and amortization22.522.5
Share-based compensation expense7.06.5
Loss on sale of assets0.10.7
Deferred compensation payments(0.4)—
Deferred income taxes(0.2)(0.1)
Other, net(0.6)(1.8)
Changes in operating assets and liabilities(106.1)(126.5)
Net cash used by operating activities$(72.9)$(86.3)
Cash Flow from Investing Activities
Capital expenditures(6.5)(11.3)
Collection of deferred purchase price on accounts receivable sold—0.4
Other, net0.5(0.3)
Net cash used by investing activities$(6.0)$(11.2)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days216.0241.0
Cash payments on debt with original maturities greater than 90 days(125.0)(141.0)
Proceeds from debt with original maturities of 90 days or less4.15.5
Repurchase of shares(15.0)(15.0)
Dividends to common shareholders(7.6)(8.3)
Net financing inflow from the Accounts Receivable Facility4.88.8
Employee shares withheld for taxes(7.0)(8.1)
Other, net(0.5)—
Net cash from financing activities$69.8$82.9
Effect of exchange rate changes on cash6.910.0
Net decrease in cash and cash equivalents(2.2)(4.6)
Cash and cash equivalents, beginning of period216.4188.7
Cash and cash equivalents, end of period$214.2$184.1

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(unaudited, in millions)

Common Shares · Treasury Shares
NumberPar ValueNumberAmountAdditional Paid-In CapitalRetained EarningsAccumulated Other Comprehensive LossTotal Shareholders’ Equity
Balance as of September 30, 202365.2$0.7(15.0)$(906.1)$1,593.8$1,022.1$(170.0)$1,540.5
Net earnings—————4.8—4.8
Foreign currency translation adjustments——————27.027.0
Pension and postretirement activity——————(0.1)(0.1)
Deferred loss on hedging activity——————(3.4)(3.4)
Dividends declared to common shareholders—————(7.6)—(7.6)
Repurchase of shares including excise tax——(0.4)(15.5)———(15.5)
Activity under share plans——0.225.0(24.9)——0.1
Balance as of December 31, 202365.2$0.7(15.2)$(896.6)$1,568.9$1,019.3$(146.5)$1,545.8
Common Shares · Treasury Shares
NumberPar ValueNumberAmountAdditional Paid-In CapitalRetained EarningsAccumulated Other Comprehensive LossTotal Shareholders’ Equity
Balance as of September 30, 202265.2$0.7(13.7)$(860.9)$1,604.3$939.1$(216.1)$1,467.1
Net earnings—————12.4—12.4
Foreign currency translation adjustments——————48.048.0
Pension and postretirement activity——————(0.2)(0.2)
Deferred gain on hedging activity——————(8.2)(8.2)
Dividends declared to common shareholders—————(8.0)—(8.0)
Repurchase of shares including excise tax——(0.4)(15.0)———(15.0)
Activity under share plans——0.425.0(26.5)——(1.5)
Balance as of December 31, 202265.2$0.7(13.7)$(850.9)$1,577.8$943.5$(176.5)$1,494.6

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited, in millions, except per share data)

Note 1 -Background and Basis of Presentation

Background

Edgewell Personal Care Company and its subsidiaries (collectively, “Edgewell” or the “Company”) is one of the world’s largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, and feminine care categories. With operations in over 20 countries, the Company’s products are widely available in more than 50 countries.

The Company conducts its business in the following three segments:

Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge, Skintimate®, Billie®, Shave Guard and our custom brands group (formerly sold under our Shave Guard and Personna® brands), as well as non-branded products. The Company’s wet shave products include razor handles and refillable blades, disposable shave products, and shaving gels and creams.

Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products, Jack Black®, Bulldog® and Cremo® men’s grooming products, Billie women’s grooming products and Wet Ones® products.

Feminine Care includes tampons, pads and liners sold under the Playtex Gentle Glide® and Sport®, Stayfree®, Carefree®, and o.b.® brands.

Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its controlled subsidiaries and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) under the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The preparation of the unaudited Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair statement have been included in the interim results reported. The fiscal year-end balance sheet data was derived from audited consolidated financial statements, but do not include all of the annual disclosures required by GAAP; accordingly, these unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Company’s audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 28, 2023.

Recently Issued Accounting Pronouncements

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)No. 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures to update income tax disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. The amendments in the ASU also remove disclosures related to certain unrecognized tax benefits and deferred taxes. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The amendments may be applied prospectively or retrospectively with early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures.

In November 2023, the FASB issued ASUNo. 2023-07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures to expand reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require that a public entity disclose, on an annual and interim basis, significant segment expenses that are regularly provided to an entity's chief operating decision maker (“CODM”), a description of other segment items by reportable segment, and any additional measures of a segment's profit or loss used by the CODM when deciding how to allocate resources. Annual disclosures are required for fiscal years beginning after December 15, 2023. Interim disclosures are required for periods within fiscal years beginning after December 15, 2024. Retrospective application is required for all prior periods presented with early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures.

Recently Adopted Accounting Pronouncements

In September 2022, the Financial Accounting Standards Board issued Accounting Standards Update 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations" which requires that a buyer in a supplier finance program disclose additional information about the program for financial statement users including a rollforward of those obligations. The Company adopted the standard as of October 1, 2023, except for amendments relating to the rollforward requirement, which is effective for fiscal years beginning after December 15, 2023.

The Company has agreements for supplier finance programs which facilitate participating suppliers’ ability to finance payment obligations of the Company with designated third-party financial institutions. The Company is not a party to the arrangements between the suppliers and the third-party financial institutions. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to finance amounts under these arrangements. The payment terms under the programs range from 60 to 120 days. As of December 31, 2023, and September 30, 2023, $24.0 and $21.8, respectively, were valid obligations under the program. The obligations are presented as Accounts payable on the Condensed Consolidated Balance Sheets.

Revision of Previously Issued Consolidated Financial Statements

As previously disclosed in the Company’s 2023 Annual Report on Form 10-K filed with the SEC on November 28, 2023, the Company evaluated aged accrued expenditures related to goods received but not yet invoiced by certain of its vendors (“GRNI”). Based upon an assessment, including evaluating the expiry of the applicable statute of limitations of the accrued expenditures, the Company concluded that $8.5 of aged accrued GRNI originating in years 2014 through 2018 were no longer required to be reflected as accounts payable on the Consolidated Balance Sheet as of September 30, 2023 and should have been reversed in prior fiscal years. The Company concluded that the misstatements were not material, either individually or in the aggregate, to its previously issued consolidated financial statements.

To correct the immaterial misstatements, the Company has revised the Consolidated Statements of Earnings and Comprehensive Income, Consolidated Statements of Cash Flows, and Consolidated Statements of Changes in Shareholders' Equity for the three months ended December 31, 2022 as well as the associated Notes to the Condensed Consolidated Financial Statements to reflect the corrections of these immaterial misstatements as of and for the three months ended December 31, 2022. There were no changes to previously issued total cash flows generated from (used by) operating, investing, or financing activities for three months ended December 31, 2022.

The following table reflects the revisions to the previously issued Consolidated Statements of Earnings and Comprehensive Income for the three months ended December 31, 2022:

As Previously ReportedAdjustmentAs Revised
Net sales$469.1$—$469.1
Cost of products sold280.1(0.6)279.5
Gross profit189.00.6189.6
Operating income31.30.631.9
Earnings before income taxes16.40.617.0
Income tax provision4.50.14.6
Net earnings11.90.512.4
Earnings per share:
Basic net earnings per share$0.23$0.01$0.24
Dilutive net earnings per share0.230.010.24
Total comprehensive income51.50.552.0

The following table reflects the revisions to the previously issued Consolidated Statements of Cash Flows for the period ended December 31, 2022.

As Previously ReportedAdjustmentAs Revised
Net earnings$11.9$0.5$12.4
Changes in operating assets and liabilities(126.0)(0.5)(126.5)

Note 2 -Restructuring Charges

Operating Model Redesign

In fiscal 2024, the Company continues to take actions to strengthen its operating model, simplify the organization and improve manufacturing and supply chain efficiency and productivity. As a result of these actions, the Company expects to incur restructuring and repositioning related charges of approximately $19 in fiscal 2024. The Company has incurred restructuring and related charges as follows:

Three Months Ended December 31,
20232022
Severance and related costs$3.9$0.9
Asset write-off and accelerated depreciation0.1—
Consulting, project implementation and management, and other exit costs2.81.9
Total restructuring and related costs (1)$6.8$2.8

(1)Restructuring and related costs of nil and $0.1 are included within Selling, general and administrative expense (“SG&A”) for the three months ended December 31, 2023 and 2022, respectively.

The following table summarizes the restructuring activities and related accrual for the three months ended December 31, 2023:

Utilized
October 1, 2023Charge toIncomeCashDecember 31,2023
Severance and related costs$3.9$4.0$(4.2)$3.7
Consulting, project implementation and management, and other exit costs0.72.8(3.5)—
Total restructuring activities and related accrual$4.6$6.8$(7.7)$3.7

Note 3 -Income Taxes

For the three months ended December 31, 2023, the Company had income tax expense of $1.2, on Earnings before income taxes of $6.0. The effective tax rate for the three months ended December 31, 2023 was 20.1%. The difference between the federal statutory rate and the effective rate is primarily due to a favorable mix of earnings in lower tax rate jurisdictions.

For the three months ended December 31, 2022, the Company had income tax expense of $4.6 on Earnings before income taxes of $17.0. The effective tax rate for the three months ended December 31, 2022 was 27.0%. The difference between the federal statutory rate and the effective rate was primarily due to an unfavorable mix of earnings in higher tax rate jurisdictions.

Note 4 -Earnings per Share

Basic earnings per share is based on the weighted-average number of common shares outstanding during the period. Diluted earnings per share is based on the number of shares used for the basic earnings per share calculation, adjusted for the dilutive effect of share options, restricted share equivalent (“RSE”) and performance restricted share equivalent (“PRSE”) awards.

The following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation:

Three Months EndedDecember 31,
20232022
Basic weighted-average shares outstanding50.151.6
Effect of dilutive securities:
Options, RSE and PRSE awards0.40.3
Total dilutive securities0.40.3
Diluted weighted-average shares outstanding50.551.9

The following weighted-average common shares were excluded from the calculation of diluted earnings per share because the effect of including these awards was antidilutive.

Three Months EndedDecember 31,
20232022
Option awards1.31.0
RSE and PRSE awards0.60.6

Note 5 -Goodwill and Intangible Assets

The following table sets forth goodwill by segment:

WetShaveSun and Skin CareFeminineCareTotal
Gross balance as of September 30, 2023$1,140.5$355.9$206.0$1,702.4
Accumulated goodwill impairment(369.0)(2.0)—(371.0)
Net balance as of September 30, 2023$771.5$353.9$206.0$1,331.4
Cumulative translation adjustment4.00.71.05.7
Gross balance as of December 31, 2023$1,144.5$356.6$207.0$1,708.1
Accumulated goodwill impairment(369.0)(2.0)—(371.0)
Net balance as of December 31, 2023$775.5$354.6$207.0$1,337.1

The following table sets forth intangible assets by class:

December 31, 2023September 30, 2023
CarryingAmountAccumulatedAmortizationNetCarryingAmountAccumulatedAmortizationNet
Indefinite lived
Trade names and brands$596.4$—$596.4$592.9$—$592.9
Amortizable
Trade names and brands$339.8$92.2$247.6$339.6$88.1$251.5
Technology and patents79.776.73.079.476.23.2
Customer related and other271.4148.3123.1269.8143.6126.2
Amortizable intangible assets690.9317.2373.7688.8307.9380.9
Total intangible assets$1,287.3$317.2$970.1$1,281.7$307.9$973.8

Amortization expense was $7.8 and $7.7 for the three months ended December 31, 2023 and 2022, respectively. Estimated amortization expense for amortizable intangible assets is as follows:

Estimated amortization expense
Remainder of fiscal year 202423.3
202531.1
202630.7
202730.5
202830.4
202930.4
Thereafter197.3

Goodwill and intangible assets deemed to have an indefinite life are not amortized but are instead reviewed annually for impairment or when indicators of a potential impairment are present. The Company’s annual impairment testing date is July 1. An interim impairment analysis may indicate that carrying amounts of goodwill and other intangible assets require adjustment or that remaining useful lives should be revised. The Company determined there was no triggering event requiring an interim impairment analysis during the three months ended December 31, 2023.

Note 6 -Supplemental Balance Sheet Information

December 31,2023September 30,2023
Inventories
Raw materials and supplies$94.1$86.3
Work in process92.291.1
Finished products335.6315.0
Total inventories$521.9$492.4
Other Current Assets
Prepaid expenses$82.5$72.5
Value added tax receivables39.843.7
Income taxes receivable25.118.9
Other9.512.3
Total other current assets$156.9$147.4
Property, Plant and Equipment
Land$18.8$18.5
Buildings144.9142.6
Machinery and equipment1,117.81,105.3
Capitalized software costs61.460.2
Construction in progress41.238.5
Total gross property, plant and equipment1,384.11,365.1
Accumulated depreciation and amortization(1,050.6)(1,027.2)
Total property, plant and equipment, net$333.5$337.9
Other Current Liabilities
Accrued advertising and sales promotion$38.1$31.5
Accrued trade allowances27.029.8
Accrued salaries, vacations and incentive compensation34.265.4
Income taxes payable6.511.9
Returns reserve36.153.5
Accrued interest9.825.0
Other94.392.4
Total other current liabilities$246.0$309.5
Other Liabilities
Pensions and other retirement benefits$59.6$58.2
Other124.9121.5
Total other liabilities$184.5$179.7

Note 7 -Accounts Receivable Facilities

The Company participates in accounts receivable facility programs both in the United States and Japan. These receivable agreements are between the Company and MUFG Bank, LTD, and the subsidiaries of both parties. Transfers under the accounts receivable repurchase agreements are accounted for as sales of accounts receivables, resulting in the receivables being derecognized from the Condensed Consolidated Balance Sheet. The purchaser assumes the credit risk at the time of sale and has the right at any time to assign, transfer, or participate any of its rights under the purchased receivables to another bank or financial institution. The purchase and sale of receivables under accounts receivable repurchase agreements is intended to be an absolute and irrevocable transfer without recourse by the purchaser to the Company for the creditworthiness of any obligor. The Company has considered its performance obligation to collect and service the receivables sold in the United States and Japan and has determined that such services are not material. The compensation received is considered acceptable servicing compensation and as such, the Company does not recognize a servicing asset or liability.

Accounts receivables sold were $216.1 and $212.1 for the three months ended December 31, 2023 and 2022, respectively. The trade receivables sold that remained outstanding as of December 31, 2023 and September 30, 2023 were $82.4 and $82.1, respectively. The net proceeds received were included in both Cash from operating activities and Cash used by investing activities on the Condensed Consolidated Statements of Cash Flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in Other expense (income), net in the Condensed Consolidated Statements of Earnings and Comprehensive Income. The loss on sale of trade receivables was $1.2 and $0.9 for the three months ended December 31, 2023 and 2022, respectively.

Note 8 -Debt

The detail of long-term debt was as follows:

December 31,2023September 30,2023
Senior notes, fixed interest rate of 5.5%, due 2028$750.0$750.0
Senior notes, fixed interest rate of 4.1%, due 2029500.0500.0
U.S. revolving credit facility (1)213.0122.0
Total1,463.01,372.0
Less unamortized debt issuance costs and discount (2)10.711.3
Total long-term debt$1,452.3$1,360.7

(1)The U.S. revolving credit facility matures in April 2025.

(2)As of December 31, 2023, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $6.5 and $4.2, respectively. As of September 30, 2023, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $6.9 and $4.4, respectively.

As of December 31, 2023 and September 30, 2023, the Company also had outstanding short-term notes payable with financial institutions with original maturities of less than 90 days of$24.2 and $19.5, respectively, with weighted-average interest rates of 3.9% for both periods. These notes were primarily outstanding international borrowings.

Note 9 -Retirement Plans

The Company has several defined benefit pension plans covering employees in the U.S. and certain employees in other countries. The plans provide retirement benefits based on years of service and compensation. The Company also sponsors or participates in several other non-U.S. pension and postretirement arrangements, including various retirement and termination benefit plans, some of which are required by local law or coordinated with government-sponsored plans, which are not significant in the aggregate and, therefore, are not included in the information presented below.

The Company’s net periodic pension and postretirement costs for its material plans were as follows:

Three Months EndedDecember 31,
20232022
Service cost$0.5$0.5
Interest cost5.35.2
Expected return on plan assets(4.9)(5.4)
Recognized net actuarial loss0.40.4
Net periodic cost$1.3$0.7

The service cost component of the net periodic cost associated with the Company’s retirement plans is recorded to Cost of products sold and SG&A on the Condensed Consolidated Statement of Earnings and Comprehensive Income. The remaining net periodic cost is recorded to Other expense (income), net on the Condensed Consolidated Statement of Earnings and Comprehensive Income.

Note 10 -Shareholders’ Equity

Share Repurchases

In January 2018, the Company’s Board of Directors (the “Board”) authorized the repurchase of up to 10.0 shares of the Company’s common stock, replacing the previous share repurchase authorization from May 2015. The Company repurchased 0.4 shares of its common stock for $15.0 during the three months ended December 31, 2023. There are 4.2 shares of common stock available for repurchase in the future under the Board’s authorization as of December 31, 2023. Any future share repurchases may be made in the open market, privately negotiated transactions, or otherwise permitted, and in such amounts and at such times as the Company deems appropriate based upon prevailing market conditions, business needs, and other factors.

Dividends

Dividend activity in the three months ended December 31, 2023 are as follows:

Date DeclaredRecord DatePayable DateAmount Per Share
August 1, 2023September 7, 2023October 4, 2023$0.15
November 2, 2023December 6, 2023January 4, 2024$0.15

On February 1, 2024, the Board declared a quarterly cash dividend of $0.15 per common share for the second fiscal quarter of 2024. The dividend will be payable on April 4, 2024 to shareholders of record as the close of business on March 7, 2024.

Dividends declared during the three months ended December 31, 2023 totaled $7.6. Payments made for dividends during the three months ended December 31, 2023 totaled $7.6.

Note 11 -Accumulated Other Comprehensive Loss

The following table presents the changes in AOCI, net of tax, by component:

ForeignCurrencyTranslationAdjustmentsPension and Post-retirement ActivityHedgingActivityTotal
Balance as of October 1, 2023$(86.9)$(86.0)$2.9$(170.0)
Other comprehensive income (loss), net of tax27.0(0.4)(2.3)24.3
Reclassifications to earnings—0.3(1.1)(0.8)
Balance as of December 31, 2023$(59.9)$(86.1)$(0.5)$(146.5)
ForeignCurrencyTranslationAdjustmentsPension and Post-retirement ActivityHedgingActivityTotal
Balance as of October 1, 2022$(131.2)$(92.6)$7.7$(216.1)
Other comprehensive (loss) income, net of tax48.0(0.5)(4.8)42.7
Reclassifications to earnings—0.3(3.4)(3.1)
Balance as of December 31, 2022$(83.2)$(92.8)$(0.5)$(176.5)

The following table presents the reclassifications out of AOCI:

Three Months EndedDecember 31, · Affected Line Item in the Condensed Consolidated Statements of Earnings
Details of AOCI Components · 2023 · 2022
Gain on cash flow hedges
Foreign exchange contracts$1.6$5.0Other expense (income), net
Income tax expense0.51.6Income tax provision
1.13.4
Amortization of defined benefit pension and postretirement items
Actuarial losses (1)$(0.4)$(0.4)
Income tax (benefit)(0.1)(0.1)Income tax provision
(0.3)(0.3)
Total reclassifications for the period$0.8$3.1

(1)These AOCI components are included in the computation of net periodic cost. See Note 9 of Notes to Condensed Consolidated Financial Statements.

Note 12 -Financial Instruments and Risk Management

In the ordinary course of business, the Company may enter into contractual arrangements (also referred to as derivatives) to reduce its exposure to foreign currency. The Company has master netting agreements with all of its counterparties that allow for the settlement of contracts in an asset position with contracts in a liability position in the event of default. The Company manages counterparty risk through the utilization of investment grade commercial banks, diversification of counterparties, and its counterparty netting arrangements. The section below outlines the types of derivatives in place as of December 31, 2023 and September 30, 2023, as well as the Company’s objectives and strategies for holding derivative instruments.

Foreign Currency Risk

A significant share of the Company’s sales is tied to currencies other than the U.S. dollar, the Company’s reporting currency. As such, a weakening of currencies relative to the U.S. dollar can have an unfavorable impact on reported earnings. Conversely, strengthening of currencies relative to the U.S. dollar can improve reported results. The primary currencies to which the Company is exposed include the euro, the Japanese yen, the British pound, the Canadian dollar, and the Australian dollar.

Additionally, the Company’s foreign subsidiaries enter into internal and external transactions that create non-functional currency balance sheet positions at the foreign subsidiary level. These exposures are generally the result of intercompany purchases, intercompany loans and, to a lesser extent, external purchases, and are revalued in the foreign subsidiary’s local currency at the end of each month. Changes in the value of the non-functional currency balance sheet positions in relation to the foreign subsidiary’s local currency results in an exchange gain or loss recorded in Other expense (income), net. The primary currency to which the Company’s foreign subsidiaries are exposed is the U.S. dollar.

Cash Flow Hedges

As of December 31, 2023, the Company maintains a cash flow hedging program related to foreign currency risk. These derivative instruments have a high correlation to the underlying exposure being hedged and have been deemed highly effective by the Company for accounting purposes in offsetting the associated risk.

The Company has forward currency contracts to hedge cash flow uncertainty associated with currency fluctuations. These transactions are accounted for as cash flow hedges. The Company had an unrealized pre-tax loss of $0.6 and an unrealized pre-tax gain of $4.4 as of December 31, 2023 and September 30, 2023, respectively, on these forward currency contracts, which are accounted for as cash flow hedges and included in AOCI. Assuming foreign exchange rates versus the U.S. dollar remain at December 31, 2023 levels over the next 12 months, the majority of the pre-tax loss included in AOCI as of December 31, 2023 is expected to be included in Other expense (income), net. Contract maturities for these hedges extend into fiscal 2025. As of December 31, 2023, there were 64 open foreign currency contracts with a total notional value of $99.9.

Derivatives not Designated as Hedges

The Company has foreign currency derivative contracts, which are not designated as cash flow hedges for accounting purposes, to hedge balance sheet exposures. Any gains or losses on these contracts are expected to be offset by exchange gains or losses on the underlying exposures and, thus, are not expected to be subject to significant market risk. The change in the estimated fair value of the foreign currency contracts for the three months ended December 31, 2023 and 2022, resulted in a loss of $1.1 and $2.7, respectively, and was recorded in Other expense (income), net in the Condensed Consolidated Statements of Earnings and Comprehensive Income. As of December 31, 2023, there were three open foreign currency derivative contracts not designated as cash flow hedges with a total notional value of $27.0.

The following table provides estimated fair values of derivative instruments:

Fair Value of Assets (Liabilities) as of (1)
December 31,2023September 30,2023
Derivatives designated as cash flow hedging relationships:
Foreign currency contracts$(0.6)$4.4
Derivatives not designated as cash flow hedging relationships:
Foreign currency contracts$(1.2)$0.9

(1)Derivative assets are presented in Other current assets or Other assets. Derivative liabilities are presented in Other current liabilities or Other liabilities.

The following table provides the pre-tax amounts of gains and losses on derivative instruments:

Three Months EndedDecember 31,
20232022
Derivatives designated as cash flow hedging relationships:
Foreign currency contracts
Gain (loss) recognized in OCI (1)$1.1$(7.1)
Gain reclassified from AOCI into income (1) (2)1.64.9
Derivatives not designated as cash flow hedging relationships:
Foreign currency contracts
Loss recognized in income (2)$1.1$2.7

(1)Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and have been deemed highly effective by the Company in offsetting associated risk.

(2)Gain was recorded in Other expense (income), net.

The following table provides financial assets and liabilities for balance sheet offsetting:

As of December 31, 2023As of September 30, 2023
Assets (1)Liabilities (2)Assets (1)Liabilities (2)
Foreign currency contracts
Gross amounts of recognized assets (liabilities)$1.2$(0.3)$6.1$(0.7)
Gross amounts offset in the balance sheet(2.8)0.1(0.2)0.4
Net amounts of assets (liabilities) presented in the balance sheet$(1.6)$(0.2)$5.9$(0.3)

(1)All derivative assets are presented in Other current assets or Other assets.

(2)All derivative liabilities are presented in Other current liabilities or Other liabilities.

Fair Value Hierarchy

Accounting guidance on fair value measurements for certain financial assets and liabilities requires that assets and liabilities carried at fair value be classified in one of the following three categories:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions or external inputs from inactive markets.

The following table sets forth the Company’s financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as Level 2 within the fair value hierarchy:

December 31,2023September 30,2023
Assets (Liabilities) at estimated fair value:
Deferred compensation liability$(20.7)$(19.4)
Derivatives - foreign currency contracts (liability) asset(1.8)5.6
Net assets (liabilities) at estimated fair value$(22.5)$(13.8)

The estimated fair value of the deferred compensation liability is determined based upon the quoted market prices of the investment options that are offered under the plan. As of December 31, 2023 and September 30, 2023, the estimated fair value of foreign currency contracts is the amount that the Company would receive or pay to terminate the contracts, considering first the quoted market prices of comparable agreements or, in the absence of quoted market prices, factors such as interest rates, currency exchange rates, and remaining maturities.

As of December 31, 2023 and September 30, 2023, the Company had no Level 1 financial assets or liabilities, other than pension plan assets, and no Level 3 financial assets or liabilities as of December 31, 2023 and September 30, 2023, respectively.

As of December 31, 2023 and September 30, 2023, the fair market value of fixed rate long-term debt was $1,139.8 and $1,028.6, respectively, compared to its carrying value of $1,250.0 in each period. The estimated fair value of the long-term debt was estimated using yields obtained from independent pricing sources for similar types of borrowing arrangements. The estimated fair value of long-term debt, excluding the Company’s credit agreement, dated as of March 28, 2020, by and among, inter alia, the Company, the subsidiaries of the Company from time to time parties thereto, the lenders from time to time parties thereto, MUFG, as syndication agent, TD as joint lead arranger and BofA, as administrative agent and collateral agent (the "Revolving Credit Facility") , has been determined based on Level 2 inputs.

Due to the nature of cash and cash equivalents and short-term borrowings, including notes payable, the carrying amounts on the balance sheets approximate fair value. Additionally, the carrying amounts of the Revolving Credit Facility, which are classified as long-term debt on the balance sheet, approximate fair value due to the revolving nature of the balances.

Note 13 -Segment Data

For an overview of the Company’s segments, refer to Note 1 of the Notes to Condensed Consolidated Financial Statements. Segment performance is evaluated based on segment profit, excluding certain U.S. GAAP items that management does not believe are indicative of ongoing operating performance due to their unusual or non-recurring nature and which may have a disproportionate positive or negative impact on the Company’s financial results in any particular period. Financial items, such as interest income and expense, are managed on a global basis at the corporate level and therefore are excluded from segment profit. The exclusion of such charges from segment results reflects management’s view on how management monitors and evaluates segment operating performance, generates future operating plans and makes strategic decisions regarding the allocation of capital.

The Company’s operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and, in most cases, combined sales force and management teams. The Company applies a fully allocated cost basis in which shared business functions are allocated between the segments.

Segment net sales and profitability are presented below:

Three Months EndedDecember 31,
20232022
Net Sales
Wet Shave$301.7$275.3
Sun and Skin Care115.4112.9
Feminine Care71.880.9
Total net sales$488.9$469.1
Segment Profit
Wet Shave$53.7$35.7
Sun and Skin Care(1.3)13.3
Feminine Care7.311.9
Total segment profit59.760.9
General corporate and other expenses(16.2)(15.9)
Amortization of intangibles(7.8)(7.7)
Interest and other expense, net(20.1)(14.9)
Restructuring and related costs (1)(6.8)(2.8)
Acquisition and integration costs (2)(0.7)(2.1)
Sun Care reformulation costs (3)(0.5)(0.5)
Wet Ones manufacturing plant fire (4)(1.5)—
Other project costs(0.1)—
Total earnings before income taxes$6.0$17.0

(1)Includes pre-tax SG&A of nil and $0.1 for the three months ended December 31, 2023 and 2022, respectively.

(2)Includes pre-tax SG&A of $0.7 and $2.1 for the three months ended December 31, 2023 and 2022, respectively, for the acquisition of Billie, Inc. on November 29, 2021.

(3)Includes pre-tax R&D of $0.5 and $0.5 for the three months ended December 31, 2023 and 2022, respectively, related to the reformulation, recall and destruction of certain Sun Care products.

(4)On December 1, 2023, a fire occurred at our Wet Ones manufacturing plant in Sidney, Ohio. There were no injuries reported and damage was limited to a single manufacturing process. As a consequence of the fire damage, there was a partial shutdown of the operations that manufacture Wet Ones raw materials. Through the three months ended December 31, 2023, the Company has incurred $1.5 in costs related to incremental material charges, labor and absorption as a result of the fire.

The following table presents the Company’s net sales by geographic area:

Three Months EndedDecember 31,
20232022
Net Sales to Customers
United States$254.2$271.8
International234.7197.3
Total net sales$488.9$469.1

Supplemental product information is presented below for net sales:

Three Months EndedDecember 31,
20232022
Razors and blades$270.5$247.0
Tampons, pads, and liners71.880.9
Sun care products51.047.8
Grooming products46.847.3
Wipes and other skin care17.617.8
Shaving gels and creams31.228.3
Total net sales$488.9$469.1

Note 14 -Commitments and Contingencies

Legal Proceedings

The Company and its subsidiaries are subject to a number of legal proceedings in various jurisdictions arising out of its operations during the ordinary course of business. Many of these legal matters are in preliminary stages and involve complex issues of law and fact and may proceed for protracted periods of time. The amount of liability, if any, from these proceedings cannot be determined with certainty. The Company reviews its legal proceedings and claims, regulatory reviews and inspections and other legal proceedings on an ongoing basis and follows appropriate accounting guidance when making accrual and disclosure decisions. The Company establishes accruals for those contingencies when the incurrence of a loss is probable and can be reasonably estimated and discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued if such disclosure is necessary for its financial statements to not be misleading. The Company does not record liabilities when the likelihood that the liability has been incurred is probable, but the amount cannot be reasonably estimated. Based upon present information, the Company believes that its liability, if any, arising from such pending legal proceedings, asserted legal claims, and known potential legal claims which are likely to be asserted, is not reasonably likely to be material to its financial position, results of operations or cash flows, when taking into account established accruals for estimated liabilities.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.